INS and Hyperglycemia: Investigation of ADAM17 upregulation in COVID-19 patients, a comparison of the outcomes of diabetic patients with and without insulin (or different brands of insulin) treatments for the management of hyperglycemia, might answer the dilemma of appropriate sugar maintenance and possibly save lives.